NIH-funded research NIH-funded research

Collaboratory advancing HIV cure research to eradicate persistent infection

Official title: Collaboratory of AIDS Researchers for Eradication (CARE)

Funded at Univ of North Carolina Chapel Hill · NIH-11515081 · Data updated 2026-11-12

A national team is pursuing new ways to cure HIV by waking up latent virus and helping the body clear infected cells, with the goal of eradicating persistent infection.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniv of North Carolina Chapel Hill
NIH-funded
Lab location1 site (Chapel Hill, United States)
Project startAugust 18, 2026
Project endJune 30, 2028
Funding year2026
Award (this year)$5,318,544
NIH project number4UM1AI164567-06
Project IDNIH-11515081 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are people living with HIV who are on stable antiretroviral therapy and may participate in future latency-reversal or clearance studies.

Less likely to help

People not compatible with future clinical latency-reversal or clearance strategies may not directly benefit.

What this research studies

This project brings together researchers, clinicians, and industry partners to test new ideas that disrupt HIV latency and promote clearance of reservoir cells. It plans pre-clinical experiments, proof-of-concept studies, and strategies to prevent viral rebound after stopping therapy. The work emphasizes collaboration across institutions to translate promising concepts toward early clinical initiatives, aiming to move beyond treatment to potential cure. Participants would benefit indirectly through advances that could inform future therapies and trials.

Why it matters

Potential benefit: If successful, the research could inform new cure strategies that reduce or eliminate HIV reservoirs and prevent rebound after treatment interruption.

How similar studies have gone: Previous MDC efforts have shown progress in latency reversal and reservoir targeting, with ongoing translation to clinical testing.

Where this research is happening

  • Univ of North Carolina Chapel Hill
    Chapel Hill, United States
    Active

Researchers

  • Principal investigator: Margolis, David M. — Univ of North Carolina Chapel Hill
  • Study coordinator: Margolis, David M.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.